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Abstract
Uranium is a ubiquitous metal that is nephrotoxic at high doses. Few epidemiologic studies have 
examined the kidney filtration impact of chronic environmental exposure. In 684 lead workers 
environmentally exposed to uranium, multiple linear regression was used to examine associations 
of uranium measured in a four-hour urine collection with measured creatinine clearance, serum 
creatinine- and cystatin-C-based estimated glomerular filtration rates, and N-acetyl-β-D-
glucosaminidase (NAG). Three methods were utilized, in separate models, to adjust uranium levels 
for urine concentration - μg uranium/g creatinine; μg uranium/L and urine creatinine as separate 
covariates; and μg uranium/4 hr. Median urine uranium levels were 0.07 μg/g creatinine and 0.02 
μg/4 hr and were highly correlated (rs =0.95). After adjustment, higher ln-urine uranium was 
associated with lower measured creatinine clearance and higher NAG in models that used urine 
creatinine to adjust for urine concentration but not in models that used total uranium excreted 
(μg/4 hr). These results suggest that, in some instances, associations between urine toxicants and 
kidney outcomes may be statistical, due to the use of urine creatinine in both exposure and 
outcome metrics, rather than nephrotoxic. These findings support consideration of non-creatinine-
based methods of adjustment for urine concentration in nephrotoxicant research.
Address correspondence to: Virginia M. Weaver, M.D., M.P.H. Division of Occupational & Environmental Health, Johns Hopkins 
University Bloomberg School of Public Health, 615 N. Wolfe St., Rm. 7041, Baltimore, MD 21205, vweaver@jhsph.edu, 
410-955-4355 (phone) and 410-955-1811 (fax). 
HHS Public Access
Author manuscript
J Expo Sci Environ Epidemiol. Author manuscript; available in PMC 2017 June 03.
Published in final edited form as:














creatinine; kidney function; metals; uranium
Introduction
Identification of environmental nephrotoxicants is increasingly important as the world-wide 
prevalence of chronic kidney disease (CKD) grows (1). Uranium, a naturally occurring 
radioactive element, is an important consideration in this regard. The US National Health 
and Nutrition Examination Survey (NHANES), a population sample considered 
representative of the non-military, non-institutionalized US general population, has 
consistently detected uranium in the urine of a majority of study participants (2). Exposure 
in the general population occurs mainly through ingestion of natural uranium in drinking 
water and in food grown in contaminated soil. Exposure to uranium via contaminated 
ground water is a global concern as elevated levels have been detected in a wide range of 
geographic areas including the United States, Canada, Scandinavian countries, central 
Australia, India, and South Korea (3–5). The main industrial uses of uranium have been as a 
power source for nuclear reactors (3) and as depleted uranium used in the manufacture of 
munitions.
Uranium is nephrotoxic at acute, high-dose exposures in humans and animals (5, 6). 
However, despite widespread environmental exposure, few data on associations between 
chronic, low-level uranium exposure and kidney outcomes are available. Limited evidence 
indicates elevated levels of kidney early biological effect markers in populations chronically 
exposed to relatively low levels of uranium (5–7). However, associations with glomerular 
filtration measures (GFR) have been inconsistent. Furthermore, the nephrotoxic effects of 
exposure to multiple metals are relatively unknown; populations co-exposed to uranium, 
lead and/or other nephrotoxic metals may be at increased risk for kidney damage. Thus, the 
data to date indicate considerable potential for nephrotoxicity associated with environmental 
uranium exposure and support the need for additional epidemiologic research. To address 
this knowledge gap, we performed a cross-sectional analysis of associations between urine 
uranium levels and kidney outcomes in 684 current and former lead workers in the Republic 
of Korea in whom cadmium, antimony, and thallium associations with kidney outcomes 
have previously been analyzed (8–10). Kidney outcomes examined include these traditional 
kidney filtration rate measures: serum creatinine- and cystatin-C-based estimated glomerular 
filtration rates (eGFR) and measured creatinine clearance. N-acetyl-β-glucosaminidase 
(NAG), an enzyme located in the lysosomes of the proximal tubule cells, was examined as 
an early biologic effect marker for the proximal tubule.
Materials and Methods
Study Overview and Design
We performed a cross-sectional analysis of data from current and former inorganic lead 
workers who were voluntary participants in a longitudinal study established to look at the 
health effects of occupational lead exposure. Data used for this analysis were obtained in the 
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fourth evaluation conducted between April 2004 and September 2005. All participants 
provided written, informed consent and the study protocol was approved by Institutional 
Review Boards at the SoonChunHyang University School of Medicine and the Johns 
Hopkins University Bloomberg School of Public Health.
Study Population
As previously described (9, 11, 12), participants were recruited via medical surveillance 
programs in 1997–9 for the first enrollment phase of the cohort study and 2004–5 for the 
second phase of the study. The population is 100% Korean. Inclusion criteria were 
occupational exposure to lead and, for phase II enrollees, age ≥ 40 years in order to enrich 
the study with participants with increased risk for adverse kidney outcomes. There were no 
medical exclusionary criteria. In order to optimize study data for both cross-sectional and 
longitudinal analyses, a urine metals panel, including uranium, thallium, and cadmium, was 
measured in the fourth evaluation of the 712 workers who participated in both the fourth and 
fifth evaluations. Workers from a primary smelter (n=28) were excluded from this analysis 
due to their potentially wider range of occupational metal exposures. Thus, cross-sectional 
analysis of data in the remaining 684 workers was the focus of the current analysis.
Data Collection
As previously described (9), data collection and biologic specimens included a standardized, 
interviewer-administered questionnaire; blood pressure obtained with the IntelliSense™ 
blood pressure monitor (Model HEM-907; Omron; Vernon Hills, IL); height and weight; a 
blood sample (for serum creatinine, cystatin C and blood lead); a four-hour urine collection 
(for uranium, thallium, cadmium and creatinine levels); a spot urine sample collected just 
before beginning the four-hour urine collection (for NAG and creatinine); and tibia lead via 
X-Ray Fluorescence. Four hour urine collections were obtained over the course of the day 
with start times from 7 am to 8 pm; 66% were started between 8 am and 11:59 am and an 
additional 28% were started between 12 pm and 3:59 pm.
Metals Exposure Assessment
Urine specimens were analyzed for metals in the Trace Elements section of the Laboratory 
of Inorganic and Nuclear Chemistry at the New York State Department of Health’s 
Wadsworth Center (Albany, NY, USA). A multi-element method based dynamic reaction 
cell-inductively coupled plasma-mass spectrometry (DRC-ICP-MS) was used (13) as 
previously described (Weaver, et al., 2011). The method detection limit (MDL) for uranium 
was calculated according to International Union of Pure and Applied Chemistry (IUPAC) 
guidelines (14). The MDL was calculated as three times the standard deviation measured in 
a urine matrix blank or low-level sample for a minimum of 10 independent analytical runs 
and is typically 0.003 μg/L for urinary uranium. At the time of analysis for this study, the 
uranium MDL for urine was 0.001 μg/L, we have found the MDL to vary between 0.001 to 
0.005 μg/L over the past 6 years. The limit of quantitation (LOQ) for uranium in urine, 
defined as 10 times the standard deviation measured in a urine matrix blank or low-level 
sample as described above is approximately 0.009 μg/L, but may vary from 0.003 to 0.015 
μg/L. Urine-based internal quality control (IQC) materials were analyzed before, during and 
after every analytical run. For uranium, the mean coefficient of variation (CV) of the IQC 
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samples over the 5-month period in which the samples were assayed was 19% at 0.03 μg/L 
(n=74), 13% at 0.06 μg/L (n=75), 10% at 0.09 μg/L (n=63). Method accuracy was assessed 
via analysis of National Institute of Science and Technology (NIST) Standard Reference 
Material (SRM) 2670a Toxic Elements in Urine (Freeze-Dried) for uranium content. Found 
values were 0.099 ± 0.006 μg/L (n=22) (certified value 0.102 ± 0.002 μg/L) in the Low 
Level and 4.88 ± 0.07 μg/L (n=22) (certified value 4.997 ± 0.071 μg/L) in the High Level. 
The Laboratory also successfully participates in the external QC program operated by the 
Institut National de Santé Publique du Québec (INSPQ), Le Centre de Toxicologie du 
Québec’s (CTQ) Intercomparison Program that includes uranium in urine. The laboratory 
routinely achieved a performance of ± 5% from the assigned target value on urine uranium 
challenges from CTQ.
Blood lead was measured with a Hitachi 8100 Zeeman background-corrected atomic 
absorption spectrophotometer (15) (Hitachi Ltd. Instruments, Tokyo, Japan). Tibia lead 
levels were assessed via a 30-minute measurement of the left mid-tibia diaphysis 
using 109Cd in a back-scatter geometry to fluoresce the K-shell X-rays of lead. The lead X-
rays were recorded with a radiation detector and then quantified and compared to calibration 
data to estimate the concentration of lead in bone (16–18).
Kidney Outcome Assessment
Serum and urine creatinine were measured with a Dimension clinical chemistry system 
using a Flex reagent cartridge in a modified kinetic Jaffe assay (model RxL; Dade Behring, 
Glasgow, DE, USA). Serum cystatin C was measured via an automated Dade Behring 
nephelometry assay on a Dimension Vista Lab System (Siemens Healthcare Diagnostics, 
Deerfield, IL, USA). The PPR NAG test kit was used to determine urine NAG 
concentrations (PPR Diagnostics Ltd, London, UK). Median inter-day CV for serum 
creatinine and cystatin C and urinary NAG samples run in duplicate were all < 10%.
Calculated kidney outcomes included measured creatinine clearance using the four-hour 
collection:
• ([urine creatinine in mg/dL × urine volume in mL]/serum creatinine in mg/dL) / 
collection time in minutes)
the Modification of Diet in Renal Disease (MDRD) creatinine-based eGFR (19, 20):
• 186.3 * (serum creatinine)−1.154 * (age)−0.203 * 0.742 (if female)
and a multi-variable cystatin-C-based equation (21):
• 127.7 × serum cystatin C−1.17 × age−0.13 × 0.91 if female
Statistical Analysis
The goals of the analysis were to: 1) evaluate associations between urine uranium levels and 
kidney outcomes in current and former lead workers, while controlling for a range of 
covariates including other metals (blood and tibia lead and urine thallium and cadmium); 
and, 2) evaluate consistency of those associations in models that differed by method of 
adjustment for urine concentration. Statistical analysis was completed using statistical 
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software from StataCorp LP (College Station, TX) (22). As previously described (8) skewed 
variable distributions (urine uranium, thallium, cadmium, creatinine, and NAG) were ln-
transformed to minimize influential outliers and comply with statistical assumptions.
In separate multiple linear regression models, uranium measured in the four-hour urine 
collection was evaluated using three different methods to adjust for urine concentration: the 
traditional approach in which the metal concentration is adjusted for urine concentration by 
dividing by urine creatinine (μg uranium/g creatinine); a more recent approach in which the 
urine metal (μg/L) and creatinine (g/L) are included as separate covariates in the regression 
model (23); and a non-creatinine-based approach using the total amount of uranium excreted 
during the four-hour urine-collection (urine uranium [μg/L] × total urine volume [L] × 4/
actual collection time [hrs] resulting in μg uranium/4 hr).
Initial regression models included a priori variables (age, gender, and BMI [weight in 
kilograms divided by the square of height in meters] and urine uranium (as ln-transformed 
μg/g creatinine, or as ln-transformed μg/L and ln-urine creatinine as separate covariates, or 
as ln-transformed μg/4 hrs). Additional covariates considered for inclusion were diabetes 
and hypertension (both based on participant report of physician diagnosis or medication 
use); regular analgesic use (based on questionnaire data on medication usage); self-reported 
work status (current vs. former lead worker); lead job duration (years); study status (phase I 
vs. phase II enrollee); systolic and diastolic blood pressure (average of three measures); 
tobacco use (smoking status: never, former, current); smoking dose ([cigarettes per day × 
years of smoking] in quartiles for current smokers and dichotomized for former smokers); 
alcohol consumption (never, former, current); education (< middle school graduate, < high 
school graduate, high school graduate, > high school); and annual income (≤ 10, 10–20, 20–
30, 30–40, and > 40 million won). Variables were retained in the final model if they 
substantially changed the uranium regression coefficient or the explanatory value (r2) of the 
model for any of the kidney outcomes; were statistically significant (p ≤ 0.05); or were 
relevant based on a priori knowledge or hypotheses inherent to this study (e.g. ln-urine 
cadmium). Blood and tibia lead and urine thallium and cadmium were added to the final 
models after all other covariates were selected.
Models were evaluated for linear regression assumptions and the presence of outlying points 
using augmented component-plus-residual plots, added-variable plots, and residual versus 
predicted plots (24, 25) and repeated without outliers when applicable. Our goal in removing 
outliers was to avoid having results driven by the 1–2% of the population who have extreme 
values for outcomes (abnormal kidney function) and/or exposure metrics. As previously 
published (12), a standard set of outlier data has been identified and removed from the 
majority of analyses done in this population to date. These data are from workers with 
known kidney disease. Other outliers related to the metals in the current analyses were also 
removed. Models were also assessed for collinearity through examination of variance 
inflation factors, all of which were below 4.3.
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Information on demographics, uranium and other metal dose biomarkers, kidney outcomes, 
and selected covariates is presented in Table 1. Males comprised 78.2 % (n=535) of the 
population. Median urine uranium levels were 0.07 μg/g creatinine and 0.02 μg excreted in 
four hours. Median levels of urine thallium and cadmium were 0.39 and 0.83 μg/g creatinine 
and 0.09 and 0.19 μg/4 hr, respectively.
Urine creatinine-adjusted urine metals were correlated with their respective total metal 
excreted concentrations (rs ≥ 0.8; p < 0.001 for all; Table 2). Other metal correlations are 
shown in Table 2. As previously published (8), the three GFR measures (MDRD eGFR, 
Cystatin-C-based eGFR, and measured creatinine clearance) were significantly correlated (p 
< 0.001); NAG was not correlated with MDRD eGFR but was negatively correlated (p < 
0.001) with the two other glomerular filtration measures. Urine creatinine, measured in the 
four-hour urine specimen, was correlated with measured creatinine clearance, spot urine 
creatinine (used for NAG adjustment), and NAG (rs= 0.33, 0.48, and −0.12 respectively; 
p<0.01 for all), but not with eGFR as determined by either the serum creatinine- or cystatin-
C-based equations.
Associations of Urine Uranium with Kidney Outcomes
In the two models that used urine creatinine to adjust for urine concentration, higher ln-urine 
uranium was associated with lower measured creatinine clearance and higher NAG after 
adjustment for age, sex, BMI, current vs. former lead worker status, phase I vs. II study 
entry, income, education, alcohol consumption, smoking dose, diastolic blood pressure, 
blood lead, tibia lead, ln-urine thallium and cadmium (Table 3; Models 1 and 2). In Model 1, 
ln-urine creatinine was entered as a separate covariate, and in Model 2, uranium and the 
other urine metals were divided by urine creatinine and the resulting variable, expressed in 
μg/g creatinine, was ln-transformed and entered so that ln-urine creatinine was not entered as 
a separate covariate. However, these associations were no longer significant when the 
uranium concentration metric was entered as μg excreted in the four-hour urine collection 
(μg/4 hr) (Table 3; Model 3). Attenuation was much greater for measured creatinine 
clearance than NAG. Uranium was not associated with either creatinine- or cystatin-C-based 
eGFR in any of the three models (Table 3) nor with serum creatinine or cystatin C (data not 
shown). Results were consistent in a priori models that adjusted for age, sex, and BMI and, 
in models with ln-urine uranium entered as μg/L, ln-urine creatinine. Specifically, significant 
associations with measured creatinine clearance and NAG were observed in the a priori 
models that used urine creatinine-based methods to adjust for urine concentration but not in 
those that used total uranium excreted (μg/4 hrs) (data not shown).
We also removed ln-urine creatinine from fully adjusted models of measured creatinine 
clearance and NAG (Model 1; Table 3). The ln-uranium association with NAG was no 
longer significant (β [95% CI] = 0.02 [−0.02, 0.05]). However, the ln-uranium association 
with measured creatinine clearance was attenuated but remained significant (β [95% CI] = 
−2.0 [−3.7, −0.3]). When ln-urine creatinine was added to fully adjusted models of measured 
creatinine clearance and NAG in which ln-uranium was entered as μg/4 hr (Model 3; Table 
3), the ln-uranium associations remained nonsignificant in both models (data not shown).
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We examined associations of urine uranium concentrations with four kidney outcome 
measures (three filtration measures [measured creatinine clearance and serum creatinine- 
and cystatin-C-based glomerular filtration rates] and NAG, a proximal tubule early 
biological effect marker) to determine the impact of environmental exposure to uranium on 
kidney function in lead-exposed workers. We employed three different methods of 
adjustment for urine concentration and compared consistency of results across the three 
respective linear regression models. Distinct differences in the associations were observed 
by method of adjustment for urine concentration. Ln-urine uranium was significantly 
associated with lower measured creatinine clearance and higher NAG in the two models that 
used urine creatinine to adjust for urine concentration, one in which urine creatinine was 
included as a separate covariate in the regression model and the other using the more 
traditional creatinine-adjusted metal (i.e., urine uranium concentration expressed in μg/g 
creatinine) as a single variable. However, associations were no longer significant when the 
third urine concentration adjustment method (total uranium excreted [μg/4 hr]) was used, 
although attenuation was much greater for measured creatinine clearance than for NAG.
Uranium is a ubiquitous heavy metal naturally found in rocks and soil. It is mined and used 
as an energy source and as depleted uranium in military munitions. Environmental exposure 
to natural uranium occurs mainly through ingestion of ground water or food (7, 26). Urine is 
the primary route of excretion for absorbed uranium (7, 26). An estimated 66% of uranium 
that enters the human bloodstream is rapidly excreted within 24 hours and nearly 90% 
within a month. The remainder is primarily distributed to bone, and to a lesser extent, liver 
and kidneys (27). The half-life in bone may range from months to years. Therefore, urine 
uranium concentration is considered to be a recent exogenous dose measure with a small 
contribution from cumulative endogenous exposure (26). Median and 95th percentile urine 
uranium levels in our population were 0.070 and 0.531 μg/g creatinine compared to 0.005 
and 0.026 μg/g creatinine, respectively, in 2005–2006 NHANES participants (28).
Nephrotoxicity has been reported in animal studies using a variety of uranium compounds. 
Morphological abnormalities and dysfunction of the proximal tubule and glomerulus have 
been reported in acute and subacute studies with proximal tubule damage reported from 
chronic exposure (5–7, 29). Decreased creatinine clearance and increased proteinuria have 
been reported in acute high dose human case reports, such as in industrial accidents (6). 
Epidemiological studies have reported associations between uranium and adverse proximal 
tubule effects. Beta 2-microglobulin is the proximal tubule biomarker that has been most 
consistently associated with uranium exposure in humans (5).
Epidemiological studies examining associations between uranium exposure and glomerular 
filtration measures are scarce and the results are inconsistent (Table 4). Findings range from 
no associations (30–34); to associations consistent with nephrotoxicity (increased serum 
creatinine) (35); to associations contrary to that expected with nephrotoxicity (i.e., lower 
serum creatinine and/or higher creatinine clearance with higher exposure) (36–41). In the 
studies in Table 4 in which NAG was included, no significant associations were observed.
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In the data herein, increased ln-urine uranium was associated with decreased measured 
creatinine clearance and increased NAG, but only if urine concentration adjustment involved 
the use of urine creatinine and not if total uranium excreted (μg/4 hr) was used as the 
exposure metric. This inconsistency is all the more perplexing since creatinine adjusted urine 
uranium (μg/g creatinine) was highly correlated with total uranium excreted (μg/4 hr); thus, 
consistent results among these exposure metrics would be expected. This suggests that the 
significant associations observed may be statistical aberrations due to the use of urine 
creatinine in both exposure and outcome metrics. Urine uranium concentration (μg/L) is 
directly divided by the four-hour urine creatinine concentration (g/L) when entered as μg/g 
creatinine; the equivalent effect is achieved when both variables are entered separately into 
the model. The same urine creatinine value was also used to calculate measured creatinine 
clearance: ([urine creatinine (expressed as mg/dL for this equation) × urine volume in mL]/
serum creatinine in mg/dL) /collection time in minutes. Futhermore, NAG was directly 
divided by the spot urine creatinine, which was correlated with the four-hour urine 
creatinine, as noted above. Thus, inverse and positive associations of urine uranium 
concentration with measured creatinine clearance and NAG, respectively, are potentially 
consistent with the use of urine creatinine in these variables. Supporting this hypothesis is 
the fact that the associations of excreted uranium (μg/4 hr) with measured creatinine 
clearance and NAG remain non-significant when urine creatinine is added to those models. 
However, removing urine creatinine from the model of measured creatinine clearance in 
which it is added as a covariate for urine concentration adjustment reduces the association 
but does not completely attenuate it.
Similarities in renal handling of urine proteins used as kidney outcome markers and protein 
bound metals were recently implicated as causal factors for observed associations between 
the two (42). In addition to glomerular filtration, creatinine is secreted in the proximal tubule 
of the kidney; organic cation and anion transporters are involved in this process (43–45). 
Uranium is a proximal tubular toxicant, however, its transport mechanisms are not well 
defined. Recent data suggest that a sodium-dependent phosphate co-transporter may be 
involved (46). Thus, currently available information does not allow a determination of the 
possible role of kidney processing in our results.
To our knowledge, there are no published studies that have compared results among 
creatinine-based methods of adjustment for urine concentration and total uranium excreted 
(μg/4 hr). However, Kurrtio et al, (2006) found no association between creatinine unadjusted 
urine uranium (μg/L) and NAG, serum cystatin C, or measured creatinine clearance, noting 
that results were similar when using creatinine-corrected urinary uranium (μg/g creatinine) 
and also when using uranium exposure measures that did not require adjustment for urine 
concentration (e.g., uranium in hair and toenails). Thus, their results are not consistent with 
our findings. Other evidence also indicates that the statistical hypothesis, if applicable, does 
not affect all urine biomarkers uniformly. Urine creatinine-adjusted thallium, cadmium, and 
antimony were not associated with measured creatinine clearance in previous analyses of the 
lead workers herein although associations with other creatinine-based kidney outcomes were 
observed (8, 9). Furthermore, the most common study design in nephrotoxicant research is 
analysis of associations between urine toxicants and kidney early biological effect markers, 
also measured in urine. Most adjust for urine concentration using urine creatinine and such 
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publications routinely report some null associations. In addition, when urine creatinine was 
removed from the two significant models in Table 3, Model 1, uranium remained associated, 
although attenuated, in the measured creatinine clearance model. Our group has published 
three recent articles in the lead worker population in which the directions of urine metal 
associations have been unexpected (8–10). Similar results have been observed with urine 
cadmium (47) and other urine exposure measures in recent NHANES analyses (48). Overall, 
these recent results suggest that the use of urine biomarkers is more complex than has been 
previously appreciated.
In conclusion, we found significant associations between urine uranium and measured 
creatinine clearance and NAG in models that used urine creatinine to adjust for urine 
concentration, but not in those using the total uranium excreted metric (μg/4 hr), an approach 
to adjust urine biomarkers for urine concentration that is less commonly employed in 
occupational and environmental studies due to the need for a timed urine collection. 
Considered in isolation, the results obtained with urine creatinine adjustment suggest 
uranium nephrotoxicity. However, when reviewed in conjunction with results from the 
excreted uranium (μg/4 hr) models, alternative interpretations must be considered, although 
the more limited attenuation observed with NAG could still be interpreted as supportive of 
nephrotoxicity. Our results suggest that some associations between urine toxicants and 
kidney outcomes may be statistical, due to the use of urine creatinine in both exposure and 
outcome metrics, rather than nephrotoxic. These findings support consideration of non-
creatinine-based methods of adjustment for urine concentration as well as non-urine based 
exposure measures (e.g., blood levels) in nephrotoxicant research. Additional studies that 
collect urine samples over a range of times, such as spot, overnight and 24-hour, and 
examine the utility of various urine concentration adjustments, e.g., urine creatinine, specific 
gravity, and osmolality, as recently published by Akerstrom and colleagues (49) are essential 
in this regard.
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BMI body mass index
Cd cadmium
Cr creatinine
CV coefficient of variation
DRC-ICP-MS dynamic reaction cell-inductively coupled plasma-mass 
spectrometer
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eGFR estimated glomerular filtration rate
GFR glomerular filtration rate
HNO3 nitric acid
ICP-MS inductively coupled plasma–mass spectrometer
IQC internal quality control
ln- natural logarithm
m2 meters squared
MDL method detection limit
MDRD Modification of Diet in Renal Disease
mg/dL milligrams per deciliter
mg/L milligrams per liter
mL milliliter
mL/min milliliters per minute
NAG N-acetyl-β-D-glucosaminidase
NHANES National Health and Nutrition Examination Survey
NIST National Institute of Standards and Technology
NU natural uranium
SD standard deviation
μg/g micrograms per gram
μmol/L micromoles per liter
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Table 1
Selected demographic, exposure, and health outcome measures in 684 lead workers1
Characteristic N (%)
Male 535 (78.2)
Current workers 450 (65.8)
Diabetes (yes) 25 (3.7)
Hypertension (yes) 84 (12.3)
Current smokers 294 (43.0)
Median Mean (SD)
Age, years 46.5 47.6 (8.0)
BMI, kg/m2 24.1 24.2 (2.9)
Systolic blood pressure, mm Hg 121.5 123.6 (15.7)
Diastolic blood pressure, mm Hg 74.5 75.1 (12.1)
Blood lead, μg/dl 21.5 23.2 (14.3)
Tibia lead, μg Pb/g bone mineral* 20.0 27.1 (29.3)
Uranium, μg/g creatinine 0.07 0.13 (0.18)
Uranium, μg/4 hr 0.02 0.03 (0.04)
Thallium, μg/g creatinine 0.39 0.44 (0.23)
Thallium, μg/4 hr 0.09 0.10 (0.06)
Cadmium,μg/g creatinine 0.83 1.0 (0.6)
Cadmium, μg/4 hr 0.19 0.21 (0.10)
MDRD GFR, ml/min/1.73 m2 95.8 97.7 (19.4)
Cystatin-C-based eGFR, ml/min/1.73 m2 112.7 112.0 (17.8)
Measured creat. clearance, ml/min 110.4 110.8 (30.9)
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